✦ LIBER ✦

358 Inhibitors of the Ras/Raf/MAPK signaling pathway sensitize pancreatic cancer cells resistant to EGFR inhibitors

✍ Scribed by V. Grünwald; M. Morgan; A. Ganser; C. Reuter

Book ID: 118621540
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 144 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)80365-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The MEK/MAPK pathway is involved in the

The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

✍ Nicola Normanno; Antonella De Luca; Monica R. Maiello; Manuela Campiglio; Maria 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

## Abstract We investigated the role of the MEK/MAPK pathway in the sensitivity/resistance of breast carcinoma cells to the EGFR tyrosine kinase inhibitor gefitinib (IRESSA). We assessed the effects of gefitinib on the growth of three breast cancer cell lines that showed high (SK‐Br‐3; IC~50~ 4 µM)

Breast cancer cells with acquired resist

Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling

✍ Nicola Normanno; Manuela Campiglio; Monica R. Maiello; Antonella De Luca; Mario 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 408 KB

Sodium phenylacetate inhibits the Ras/MA

Sodium phenylacetate inhibits the Ras/MAPK signaling pathway to induce reduction of the c-Raf-1 protein in human and canine breast cancer cells

✍ Manabu Watanabe; Nozomi Miyajima; Maki Igarashi; Yoshifumi Endo; Natsuko Watanab 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 526 KB

The fibroblast growth factor receptor si

The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer

✍ Scott A. Kono; Marianne E. Marshall; Kathryn E. Ware; Lynn E. Heasley 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 523 KB

Hyperactivation of MEK–ERK1/2 signaling

Hyperactivation of MEK–ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells

✍ Kaplan, F M; Shao, Y; Mayberry, M M; Aplin, A E 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 436 KB

The sensitivity of lung cancer cell line

The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 (‘Iressa’11Iressa’ is a trademark of the AstraZeneca group of companies.) is not related to the expression of EGFR or HER-2 or to K-ras gene status

✍ Suzuki, Takeshi; Nakagawa, Taku; Endo, Hideki; Mitsudomi, Tetsuya; Masuda, Akira 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 297 KB